PCM Team2 days ago2 minRFP Questions You Should be AskingWhen evaluating a PBM contract at renewal or mid-term market check, brokers and plan sponsors should be asking questions. Questions that...
PCM TeamMar 242 minValidating Pharmacy Savings ProgramsAmericans spent $328 billion on prescription drugs in 2020, eight percent of total healthcare spend. The rising cost of medications is...
PCM TeamFeb 242 minNavigating Gene Therapies Research on gene-therapies began in 1960 with the hypothesis that introducing DNA sequences into patients' cells could cure genetic...
PCM TeamJan 182 minA Primer on J Codes High-cost prescription drugs have been wreaking havoc on pharmacy plan budgets for over a decade. However, did you know that drugs costs...
PCM TeamDec 16, 20213 minTrends to Follow in 2022This year saw a post-pandemic return to preventive care, the introduction of several biosimilars, and legislation governing healthcare...
PCM TeamOct 25, 20213 minData and Vendor Fragmentation in Health BenefitsBy identifying data and vendor silos that affect participant engagement and spend, payors and brokers can begin to build better benefits.
PCM TeamSep 10, 20213 minArtificial Intelligence in Pharmacy: Improving Patient OutcomesWith its unique set of challenges, the pharmacy industry is already benefiting from AI-powered technology;
PCM TeamAug 18, 20212 minCovering Specialty Drugs: Medical vs. Pharmacy ChannelFor self-insured plan sponsors, specialty drugs represent 33-50% of total pharmacy spend but only account for 1% of total prescription...
PCM TeamJun 14, 20212 minDrug Rebates Affect Formulary ManagementIt is not surprising that there is little transparency around the factors influencing formulary development—chief among those: rebates.
PCM TeamMay 12, 20213 minA Primer on BiosimilarsThe proven efficacy, safety, and cost savings of biosimilars make them a valuable weapon in the fight for more access to lower-cost
PCM TeamApr 15, 20213 minImproving Medication AdherenceWhen paired with proactive participant engagement, data analytics can help plan sponsors improve medication adherence.
PCM TeamMar 17, 20213 minThree Plan Metrics Every Employer Should Be Monitoring60% of employers report that the cost of their current pharmacy plan is unsustainable. Without requesting bids from vendors or...
PCM TeamFeb 17, 20212 minAchieve Lowest Net Cost with Clinically Driven FormularyA clinically-driven, value-based pharmacy model moves the plan toward the lowest net cost.
Dr. David Merritt PharmD, RPhDec 15, 20203 minPharmacy: Looking forward to 2021This year has been, in a word, unique. Fortunately, time marches on, and a new year is around the corner. This article looks forward to...
PCM TeamNov 17, 20203 minTransparency Brings Balance to Drug RebatesThere are six significant stakeholders in the complex drug distribution system: pharmaceutical manufacturer, plan sponsor, pharmacy, PBM,...
Dr. David Merritt PharmD, RPhOct 9, 20203 minSpecialty Drugs: What are they and what (or who) controls costs?The cost of prescription medications is rising, but one sub-set of drugs may be disproportionately eating away at financial resources....
PCM TeamAug 5, 20203 minPharmacy Analytics: How to Lead with DataIn the pharmacy space, industry leaders are embracing data analytics to distance themselves from the competition and provide top-level benef
Dr. David Merritt PharmD, RPhJun 22, 20204 minCOVID-19 Treatment: Where Are We?As some states lift stay-at-home orders amid growing numbers of COVID-19 cases, scientists worldwide are working on potential treatments...
Dr. David Merritt PharmD, RPhMay 6, 20204 minAnother COVID-19 side effect: Drug shortagesEven before COVID-19 wreaked havoc on the United States’ healthcare system, the availability and price of prescription drugs were a...
PCM TeamMar 31, 20203 minCreating emergency medication reservesThe severe state of emergency facing our global community has resulted in many of us staying home in a united effort to stop the spread...